US Patent Issued to BIO-RAD LABORATORIES on April 14 for "Biomarker combinations to simultaneously evaluate non-alcoholic steatohepatitis and hepatic fibrosis status" (Swiss, American Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,601,747, issued on April 14, was assigned to BIO-RAD LABORATORIES INC. (Hercules, Calif.).

"Biomarker combinations to simultaneously evaluate non-alcoholic steatohepatitis and hepatic fibrosis status" was invented by Isabelle Batxelli-Molina (Basel, Switzerland), Florian Salipante (Basel, Switzerland), Roger P. Walker (Benicia, Calif.), John Flanagan (Walnut Creek, Calif.) and Jeannette Fareh-Michiel (Basel, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides a method of diagnosing Non-Alcoholic Steatohepatitis (NASH) and/or the hepatic fibrosis status of a subject, especially a subject afflicted with Non-alcoholic fatty l...